{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:07:39Z","timestamp":1773234459299,"version":"3.50.1"},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,5,27]],"date-time":"2009-05-27T00:00:00Z","timestamp":1243382400000},"content-version":"vor","delay-in-days":4560,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Ophthalmologica Scandinavica"],"published-print":{"date-parts":[[1996,12]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title><jats:p><jats:italic>Purpose:<\/jats:italic>Topical carbonic anhydrase inhibitors such as dorzolamide have been developed as ocular hypotensive agents devoid of the side effects plaguing their systemic predecessors. We evaluated the influence of dorzolamide on retinal and retrobulbar blood flow markers to determine if the drug has orbital vascular as well as ocular hypotensive effects.<\/jats:p><jats:p><jats:italic>Methods:<\/jats:italic>Eleven persons with healthy eyes received either placebo or two drops 2% dorzolamide, 2 h prior to studies conducted in double\u2010masked, counterbalanced fashion. Four retrobulbar vessels (nasal and temporal posterior ciliary, central retinal, and ophthalmic arteries) were analyzed by color Doppler imaging; scanning laser ophthalmoscopy was used to examine retinal and superficial optic nerve head blood linear velocity.<\/jats:p><jats:p><jats:italic>Results:<\/jats:italic>Dorzolamide lowered IOP from 15.7 \u00b1 0.7 to 13.7 \u00b1 0.7 mmHg (p &lt; 0.05). The drug also hastened retinal arteriovenous passage of fluorescein dye, and accelerated capillary dye transit in the macula and optic nerve head. The drug, however, left unaltered blood velocity or resistance index in any retrobulbar vessel.<\/jats:p><jats:p><jats:italic>Conclusions:<\/jats:italic>Dorzolamide is an effective ocular hypotensive agent that accelerates blood velocity in the retinal and superficial optic nerve head without an apparent effect upon retrobulbar hemodynamics.<\/jats:p>","DOI":"10.1111\/j.1600-0420.1996.tb00737.x","type":"journal-article","created":{"date-parts":[[2009,5,27]],"date-time":"2009-05-27T23:53:59Z","timestamp":1243468439000},"page":"569-572","source":"Crossref","is-referenced-by-count":79,"title":["Effects of topical dorzolamide on retinal and retrobulbar hemodynamics"],"prefix":"10.1111","volume":"74","author":[{"given":"Alon","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Arend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Arend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,5,27]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(54)92027-9"},{"key":"e_1_2_1_3_1","first-page":"2581","article-title":"pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors","volume":"34","author":"Brechue WF","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(90)32627-1"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1989.85"},{"key":"e_1_2_1_6_1","first-page":"504","article-title":"The acute effect of oral acetazolamide on macular blood flow","volume":"33","author":"Grunwald JE","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)76579-1"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.54.7.461"},{"key":"e_1_2_1_9_1","first-page":"97","article-title":"Topical carbonic anhydrase inhibitors: a new perspective in glaucoma therapy","volume":"2","author":"Hiett JA","year":"1992","journal-title":"Optom Clin"},{"key":"e_1_2_1_10_1","first-page":"113","article-title":"Topical carbonic anhydrase inhibitors","volume":"2","author":"Higginbotham E.","year":"1989","journal-title":"Ophthalmol Clin North Am"},{"key":"e_1_2_1_11_1","first-page":"50","article-title":"Dorzolamide: a brief overview","volume":"10","author":"Higginbotham E.","year":"1994","journal-title":"Chibret Int J Ophthalmol"},{"key":"e_1_2_1_12_1","first-page":"513","article-title":"Local tolerance and effectiveness of a new local carbonic anhydrase inhibitor in healthy probands","volume":"88","author":"Hofmann HM","year":"1991","journal-title":"Fortschr Ophthalmol"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1992.01080160073033"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(91)32295-4"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.430100407"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0026-895X(25)13290-2","article-title":"Chemical properties of carbonic anhydrase IV, the membrane\u2010bound enzyme","volume":"44","author":"Maren TH","year":"1993","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_17_1","first-page":"37","article-title":"Clinical efficacy of a topical carbonic anhydrase inhibitor in open\u2010angle glaucoma","volume":"10","author":"S\u00e1nchez\u2010Thorin J C","year":"1994","journal-title":"Chibret Int J Ophthalmol."},{"key":"e_1_2_1_18_1","first-page":"116","volume-title":"Statistical Methods","author":"Snedecor GW","year":"1980"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/jop.1991.7.201","article-title":"The effect of cyclooxygenase inhibition on the ocular hypotensive action of topical carbonic anhydrase inhibitors in rabbits","volume":"7","author":"Sugrue MF","year":"1991","journal-title":"J Ocular Pharmacol"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1995.01100020100038"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1993.01090100051026"}],"container-title":["Acta Ophthalmologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0420.1996.tb00737.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0420.1996.tb00737.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T18:49:06Z","timestamp":1739126946000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0420.1996.tb00737.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["10.1111\/j.1600-0420.1996.tb00737.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0420.1996.tb00737.x","archive":["Portico"],"relation":{},"ISSN":["1395-3907","1600-0420"],"issn-type":[{"value":"1395-3907","type":"print"},{"value":"1600-0420","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,12]]}}}